Clinical Trial Update: Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating bendamustine with or without cyclophosphamide to prevent graft-versus-host disease in patients undergoing stem cell transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Drugs mentioned

• Bendamustine (Bendamustine)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematopoietic and Lymphoid System Neoplasm | Phase 1, Phase 2 | Status: RECRUITING